Development of gastroretentive fibrous dosage form for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors

Research unit

INNOSUISSE

Project number

106.127 IP-LS

Project title

Development of gastroretentive fibrous dosage form for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Pharmaceuticals
Abstract (English)	We propose the development of a gastroretentive dosage form for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. It is hoped that the dosage form will enable to maintain a steady drug concentration in blood for enhancing efficacy and reducing side effects of cancer therapies.